Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners

July 05, 2020

FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.

Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations

June 30, 2020

FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.

5 Developments Changing the CAR-T Landscape

June 28, 2020

An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.

Out-of-Pocket Costs for Diabetes Medicine Eliminated

January 31, 2020

New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.

Top Issues Facing Pharma in 2020

January 11, 2020

Novel drugs, value-based contracting, biosimilars, and regulatory activity addressing costs will be among the hot button issues in the coming year.

Will Outcomes-Based Payments Hit COPD Drugs?

November 29, 2018

In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?

Will Drug Price Hikes Impact Drug Spending?

November 28, 2018

Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.

‘Encouraging’ COPD drug pipeline could ease symptoms, address root causes

November 07, 2017

Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.